AFT outlicenses Maxigesic in South America

21 June 2019 - Deborah Wilkes

Premium

New Zealand's AFT Pharmaceuticals has announced its first outlicensing deal for the Maxigesic combination painkiller in South America.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: